CORE Trademark

Trademark Overview

On Friday, January 6, 2023, a trademark application was filed for CORE with the United States Patent and Trademark Office. The USPTO has given the CORE trademark a serial number of 97744432. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, August 21, 2024. This trademark is owned by Predictive Oncology Inc.. The CORE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; scientific research, namely, providing data analytics and data modelling that uses artificial intelligence to others in the fields of medical and pharmaceutical research and development
core

General Information

Serial Number97744432
Word MarkCORE
Filing DateFriday, January 6, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical research; scientific research, namely, providing data analytics and data modelling that uses artificial intelligence to others in the fields of medical and pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 30, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePredictive Oncology Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEagan, MN 55121

Trademark Events

Event DateEvent Description
Tuesday, January 10, 2023NEW APPLICATION ENTERED
Monday, October 16, 2023NON-FINAL ACTION E-MAILED
Monday, January 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 29, 2023ASSIGNED TO EXAMINER
Monday, October 16, 2023NON-FINAL ACTION WRITTEN
Monday, October 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 1, 2024ASSIGNED TO LIE
Wednesday, August 21, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, August 21, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 21, 2024SUSPENSION LETTER WRITTEN
Monday, July 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

core research medical data others intelligence fields development pharmaceutical artificial modelling